These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31189997)

  • 41. Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes.
    Yamada Y; Kuda M; Kohashi K; Yamamoto H; Takemoto J; Ishii T; Iura K; Maekawa A; Bekki H; Ito T; Otsuka H; Kuroda M; Honda Y; Sumiyoshi S; Inoue T; Kinoshita N; Nishida A; Yamashita K; Ito I; Komune S; Taguchi T; Iwamoto Y; Oda Y
    Virchows Arch; 2017 Apr; 470(4):373-380. PubMed ID: 28197724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
    Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
    Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pleomorphic Liposarcoma Arising in a Lipoleiomyosarcoma of the Uterus: Report of a Case With Genetic Profiling by a Next Generation Sequencing Panel.
    Schoolmeester JK; Stamatakos MD; Moyer AM; Park KJ; Fairbairn M; Fader AN
    Int J Gynecol Pathol; 2016 Jul; 35(4):321-6. PubMed ID: 26598981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ZC3H7B-BCOR High-Grade Endometrial Stromal Sarcoma with a Mucoid Grossly Feature: A Case Report and Literature Review.
    Zhi W; Zheng X; Jin Y
    Int J Womens Health; 2022; 14():1701-1708. PubMed ID: 36540849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myxoid epithelioid smooth muscle tumor of the vulva: A distinct entity with MEF2D::NCOA2 gene fusion.
    Warmke LM; Mustafa A; Zou YS; Davis JL; Ulbright TM; Segura SE
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23209. PubMed ID: 37870842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound and clinical characteristics of uterine smooth muscle tumors of uncertain malignant potential (STUMPs).
    Cotrino I; Carosso A; Macchi C; Baima Poma C; Cosma S; Ribotta M; Viora E; Sciarrone A; Borella F; Zola P
    Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():167-172. PubMed ID: 32505056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.
    Chiang S; Samore W; Zhang L; Sung YS; Turashvili G; Murali R; Soslow RA; Hensley ML; Swanson D; Dickson BC; Stewart CJR; Oliva E; Antonescu CR
    Am J Surg Pathol; 2019 Jun; 43(6):810-818. PubMed ID: 30829727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paediatric BCOR-associated sarcomas with a novel long spliced internal tandem duplication of BCOR exon 15.
    Goh JY; Kuick CH; Sugiura M; Aw SJ; Zhao M; Tang H; Gunaratne S; Zhu F; Cai L; Teh BT; Thorner PS; Chang KTE
    J Pathol Clin Res; 2022 Sep; 8(5):470-480. PubMed ID: 35836306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MED12 alterations in both human benign and malignant uterine soft tissue tumors.
    Pérot G; Croce S; Ribeiro A; Lagarde P; Velasco V; Neuville A; Coindre JM; Stoeckle E; Floquet A; MacGrogan G; Chibon F
    PLoS One; 2012; 7(6):e40015. PubMed ID: 22768200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.
    Schaefer IM; Hornick JL; Sholl LM; Quade BJ; Nucci MR; Parra-Herran C
    Histopathology; 2017 Jun; 70(7):1138-1146. PubMed ID: 28130839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated mutational landscape analysis of uterine leiomyosarcomas.
    Choi J; Manzano A; Dong W; Bellone S; Bonazzoli E; Zammataro L; Yao X; Deshpande A; Zaidi S; Guglielmi A; Gnutti B; Nagarkatti N; Tymon-Rosario JR; Harold J; Mauricio D; Zeybek B; Menderes G; Altwerger G; Jeong K; Zhao S; Buza N; Hui P; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Ardighieri L; Bilguvar K; Quick CM; Silasi DA; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Imielinski M; Schwartz PE; Alexandrov LB; Lifton RP; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCOR involvement in cancer.
    Astolfi A; Fiore M; Melchionda F; Indio V; Bertuccio SN; Pession A
    Epigenomics; 2019 May; 11(7):835-855. PubMed ID: 31150281
    [No Abstract]   [Full Text] [Related]  

  • 53. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors.
    Devereaux KA; Kunder CA; Longacre TA
    Am J Surg Pathol; 2019 Jan; 43(1):64-74. PubMed ID: 29794871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors.
    Esposito NN; Hunt JL; Bakker A; Jones MW
    Am J Surg Pathol; 2006 Jan; 30(1):97-103. PubMed ID: 16330948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
    Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
    Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.
    Ravegnini G; Mariño-Enriquez A; Slater J; Eilers G; Wang Y; Zhu M; Nucci MR; George S; Angelini S; Raut CP; Fletcher JA
    Mod Pathol; 2013 May; 26(5):743-9. PubMed ID: 23222489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential.
    Ip PP; Cheung AN
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):691-704. PubMed ID: 21865091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PD-L1 Expression and Tumor-infiltrating Lymphocytes in Uterine Smooth Muscle Tumors: Implications for Immunotherapy.
    Shanes ED; Friedman LA; Mills AM
    Am J Surg Pathol; 2019 Jun; 43(6):792-801. PubMed ID: 31009388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.